Overview
Idiopathic Anemia of Aging (IAA)
Status:
Terminated
Terminated
Trial end date:
2007-05-01
2007-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this trial is to examine whether Epoetin Alfa, a hormone stimulating production of red blood cells, can reverse idiopathic anemia.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
National Institute on Aging (NIA)Treatments:
Epoetin Alfa
Criteria
Inclusion Criteria:- 70 years of age or older
- Diagnosed with anemia
- Hemoglobin level less than or equal to 11
- Able to perform most activities of daily living without restriction
Exclusion Criteria:
- History of serious heart, liver or kidney disease
- Cancer treated within the last year except for skin cancer (excluding melanoma)
- Problems with your immune system
- Received Epoetin Alfa within the last year